IL229485A0 - Pyrazole derivatives useful as aldosterone synthase inhibitors - Google Patents

Pyrazole derivatives useful as aldosterone synthase inhibitors

Info

Publication number
IL229485A0
IL229485A0 IL229485A IL22948513A IL229485A0 IL 229485 A0 IL229485 A0 IL 229485A0 IL 229485 A IL229485 A IL 229485A IL 22948513 A IL22948513 A IL 22948513A IL 229485 A0 IL229485 A0 IL 229485A0
Authority
IL
Israel
Prior art keywords
pyrazoles
history
act
synthesis inhibitors
aldosterone synthesis
Prior art date
Application number
IL229485A
Other languages
English (en)
Hebrew (he)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL229485(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL229485A0 publication Critical patent/IL229485A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL229485A 2011-06-14 2013-11-18 Pyrazole derivatives useful as aldosterone synthase inhibitors IL229485A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11
PCT/US2012/041212 WO2012173849A1 (en) 2011-06-14 2012-06-07 Pyrazole derivatives useful as aldosterone synthase inhibitors

Publications (1)

Publication Number Publication Date
IL229485A0 true IL229485A0 (en) 2014-01-30

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
IL229485A IL229485A0 (en) 2011-06-14 2013-11-18 Pyrazole derivatives useful as aldosterone synthase inhibitors

Country Status (33)

Country Link
US (1) US8778984B2 (enExample)
EP (1) EP2721009B1 (enExample)
JP (1) JP5890012B2 (enExample)
KR (1) KR101555119B1 (enExample)
CN (1) CN103596930B (enExample)
AR (1) AR086665A1 (enExample)
AU (1) AU2012271023A1 (enExample)
BR (1) BR112013031873A2 (enExample)
CA (1) CA2836804C (enExample)
CL (1) CL2013003536A1 (enExample)
CO (1) CO6821955A2 (enExample)
CR (1) CR20130601A (enExample)
CY (1) CY1116687T1 (enExample)
DK (1) DK2721009T3 (enExample)
DO (1) DOP2013000284A (enExample)
EA (1) EA201391655A1 (enExample)
EC (1) ECSP13013080A (enExample)
ES (1) ES2548210T3 (enExample)
GT (1) GT201300307A (enExample)
HR (1) HRP20150939T1 (enExample)
HU (1) HUE026461T2 (enExample)
IL (1) IL229485A0 (enExample)
ME (1) ME02223B (enExample)
MX (1) MX336042B (enExample)
PE (1) PE20140606A1 (enExample)
PH (1) PH12013502597A1 (enExample)
PL (1) PL2721009T3 (enExample)
PT (1) PT2721009E (enExample)
RS (1) RS54269B1 (enExample)
SG (1) SG194822A1 (enExample)
SI (1) SI2721009T1 (enExample)
TW (1) TWI518073B (enExample)
WO (1) WO2012173849A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
JPWO2007111175A1 (ja) 2006-03-17 2009-08-13 日本碍子株式会社 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102711916B (zh) 2010-01-14 2015-09-02 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
AU2012271023A1 (en) 2013-11-28
ME02223B (me) 2016-02-20
MX2013014790A (es) 2014-01-24
EP2721009A1 (en) 2014-04-23
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
WO2012173849A1 (en) 2012-12-20
EP2721009B1 (en) 2015-08-12
PL2721009T3 (pl) 2016-01-29
KR101555119B1 (ko) 2015-09-22
CR20130601A (es) 2014-05-02
CN103596930B (zh) 2015-05-13
PH12013502597A1 (en) 2018-04-11
TW201311647A (zh) 2013-03-16
ES2548210T3 (es) 2015-10-14
JP2014517034A (ja) 2014-07-17
PT2721009E (pt) 2015-10-23
HUE026461T2 (en) 2016-05-30
DOP2013000284A (es) 2014-06-30
JP5890012B2 (ja) 2016-03-22
RS54269B1 (sr) 2016-02-29
PE20140606A1 (es) 2014-05-17
DK2721009T3 (en) 2015-10-26
CN103596930A (zh) 2014-02-19
EA201391655A1 (ru) 2014-07-30
CA2836804C (en) 2016-05-24
NZ617642A (en) 2015-11-27
HRP20150939T1 (xx) 2015-10-09
ECSP13013080A (es) 2014-01-31
MX336042B (es) 2016-01-07
TWI518073B (zh) 2016-01-21
SG194822A1 (en) 2013-12-30
CO6821955A2 (es) 2013-12-31
CY1116687T1 (el) 2017-03-15
GT201300307A (es) 2014-11-24
US8778984B2 (en) 2014-07-15
US20120322841A1 (en) 2012-12-20
HK1193103A1 (en) 2014-09-12
AR086665A1 (es) 2014-01-15
SI2721009T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
CY2022018I1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
IL227764A0 (en) Pyrrolotriazinone derivatives as pi3k inhibitors
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
SMT201700109B (it) Inibitori di istone demetilasi
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
SMT201600238B (it) Inibitori di protein chinasi
SMT201700111B (it) Eterociclilammine come inibitori di pi3k
LT2895484T (lt) Gliukozilceramido sintazės inhibitoriai
SMT201600141B (it) Boronati quali inibitori di arginasi
HUE040455T2 (hu) T-sejt aktiválás inhibitorai
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
SMT201700094B (it) Composto di pirazina carbossammide
SMT201500271B (it) Inibitori di neprilisina
BR112014000445A2 (pt) usos de inibidores de hsp90 marcados
CO6960542A2 (es) Polimorfos de inhibidores de cinasas
CO7010824A2 (es) Inhibidores de aplicación viral
EP2736491A4 (en) BEPOTASTIN COMPOSITION
DK3178818T3 (da) Pyrazolylquinoxalinkinasehæmmere
HRP20180809T1 (hr) Inhibicijski spojevi metaloenzima
SMT201600001B (it) Imidazopiridazine come inibitori di akt chinasi
BR112014003878A2 (pt) síntese de r-bifenilalaninol
PL2772482T3 (pl) Pochodna azolu
PL2906551T3 (pl) Postacie krystaliczne inhibitora czynnika xia
SMT201600328B (it) Nuovi composti come inibitori di diacilglicerolo aciltransferasi
EP2763533A4 (en) Triazolyl PDE10 INHIBITORS